Aluminum Hydroxide And Magnesium Trisilicate



Indications and Reactions:

Role Indications Reactions
Primary
Abdominal Discomfort 26.7%
Dyspepsia 13.3%
Gastric Ulcer Haemorrhage 13.3%
Pain 13.3%
Drug Use For Unknown Indication 6.7%
Flatulence 6.7%
Gastric Ulcer 6.7%
Gastrooesophageal Reflux Disease 6.7%
Lung Infection 6.7%
Death 23.1%
Off Label Use 15.4%
Anaphylactic Reaction 7.7%
Aphagia 7.7%
Feeling Abnormal 7.7%
Incorrect Drug Administration Duration 7.7%
Muscle Spasms 7.7%
Pain 7.7%
Renal Failure 7.7%
Therapeutic Response Unexpected 7.7%
Secondary
Drug Use For Unknown Indication 34.9%
Drug Exposure During Pregnancy 23.7%
Influenza 6.6%
Pyrexia 3.9%
Product Used For Unknown Indication 3.3%
Gastrooesophageal Reflux Disease 2.6%
Hypertension 2.6%
Upper Aerodigestive Tract Infection 2.6%
Vomiting 2.6%
Colitis Ulcerative 2.0%
Diarrhoea 2.0%
Gastroenteritis 2.0%
Ill-defined Disorder 2.0%
Acute Myeloid Leukaemia 1.3%
Chronic Obstructive Pulmonary Disease 1.3%
Depression 1.3%
Evidence Based Treatment 1.3%
Leukaemia 1.3%
Mycosis Fungoides 1.3%
Peptic Ulcer 1.3%
Cardiac Arrest 8.0%
Hypoglycaemia 8.0%
Jaundice Neonatal 8.0%
Staphylococcal Infection 8.0%
Toxic Skin Eruption 8.0%
Abdominal Pain Upper 4.0%
Acute Febrile Neutrophilic Dermatosis 4.0%
Death 4.0%
Dehydration 4.0%
Diarrhoea 4.0%
Disease Recurrence 4.0%
Dyskinesia 4.0%
Erythema Infectiosum 4.0%
Faecaloma 4.0%
General Physical Health Deterioration 4.0%
Hepatitis 4.0%
Hyperkalaemia 4.0%
Incorrect Drug Administration Duration 4.0%
Mesothelioma 4.0%
Metabolic Acidosis 4.0%
Concomitant
Diarrhoea 10.5%
Drug Use For Unknown Indication 10.2%
Product Used For Unknown Indication 9.2%
Non-small Cell Lung Cancer 8.5%
Hypertension 7.8%
Hepatitis C 5.8%
Crohn's Disease 5.5%
Acute Lymphocytic Leukaemia 4.3%
Rheumatoid Arthritis 4.1%
Multiple Myeloma 3.9%
Renal Transplant 3.9%
Unevaluable Event 3.5%
Diabetes Mellitus 3.3%
Prophylaxis 3.2%
Anxiety 3.1%
Pulmonary Arterial Hypertension 3.1%
Abdominal Pain 3.0%
Gastrointestinal Disorder 2.5%
Depression 2.4%
Hiv Infection 2.3%
Renal Failure 19.2%
Thrombocytopenia 8.8%
Renal Failure Acute 6.4%
Septic Shock 5.6%
Vomiting 5.6%
White Blood Cell Count Decreased 5.6%
Cytolytic Hepatitis 4.8%
Toxic Epidermal Necrolysis 4.8%
Anaemia 4.0%
Pneumothorax 4.0%
Weight Decreased 4.0%
Crohn's Disease 3.2%
Death 3.2%
Deep Vein Thrombosis 3.2%
Neutropenia 3.2%
Sepsis 3.2%
Subileus 3.2%
Toxic Skin Eruption 3.2%
Basal Cell Carcinoma 2.4%
Condition Aggravated 2.4%